Bibliographic Details
| Title: |
BRAZILIAN IBD STUDY GROUP POSITION STATEMENT ON SARS-COV2 VACCINATION |
| Authors: |
QUEIROZ, Natália Sousa Freitas, TEIXEIRA, Fábio Vieira, FREIRE, Caio Cesar Furtado, MOTTA, Marina Pamponet, VASCONCELLOS, Marcela Almeida Menezes de, CHEBLI, Liliana Andrade, SAAD-HOSSNE, Rogerio |
| Source: |
Arquivos de Gastroenterologia. March 2021 58(1) |
| Publisher Information: |
Instituto Brasileiro de Estudos e Pesquisas de Gastroenterologia e Outras Especialidades - IBEPEGE., 2021. |
| Publication Year: |
2021 |
| More Details: |
Mass vaccination offers the best strategy to fight against COVID-19 pandemic, and SARS-CoV2 vaccines are being approved in several countries for emergency use. In Brazil, vaccine approval is expected in the next few days, however potential concerns exist regarding vaccine recommendations for specific populations, such as patients with inflammatory bowel disease (IBD). To address these questions, the Brazilian IBD Study Group (GEDIIB) provides this practical advice with key recommendations about the COVID-19 vaccines in IBD population. |
| File Description: |
text/html |
| Language: |
English |
| ISSN: |
0004-2803 |
| DOI: |
10.1590/s0004-2803.202100000-02 |
| Access URL: |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0004-28032021000100001 |
| Rights: |
info:eu-repo/semantics/openAccess |
| Accession Number: |
edssci.S0004.28032021000100001 |
| Database: |
SciELO |
